Order Article Reprints

Mazzaschi G, Olivari A, Pavarani A, Lagrasta CAM, Frati C, Madeddu D, Lorusso B, Dallasta S, Tommasi C, Musolino A, et al. Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma. Cancers. 2022; 14(13):3249. https://doi.org/10.3390/cancers14133249

Mazzaschi, Giulia, Alessandro Olivari, Antonio Pavarani, Costanza Anna Maria Lagrasta, Caterina Frati, Denise Madeddu, Bruno Lorusso, Silvia Dallasta, Chiara Tommasi, Antonino Musolino, and et al. 2022. "Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma" Cancers 14, no. 13: 3249. https://doi.org/10.3390/cancers14133249

Mazzaschi, G., Olivari, A., Pavarani, A., Lagrasta, C. A. M., Frati, C., Madeddu, D., Lorusso, B., Dallasta, S., Tommasi, C., Musolino, A., Tiseo, M., Michiara, M., Quaini, F., & Crafa, P. (2022). Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma. Cancers, 14(13), 3249. https://doi.org/10.3390/cancers14133249